14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:FPRX
Delisted

Five Prime Therapeutics Stock Price (Quote)

$38.00
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.00 $38.00 Friday, 27th May 2022 FPRX stock ended at $38.00. During the day the stock fluctuated 0% from a day low at $38.00 to a day high of $38.00.
90 days $38.00 $38.00
52 weeks $38.00 $38.00

Historical Five Prime Therapeutics prices

Date Open High Low Close Volume
Oct 22, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 21, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 20, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 19, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 18, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 15, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 14, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 13, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 12, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 11, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 08, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 07, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 06, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 05, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 04, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 01, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 30, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 29, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 28, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 27, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 24, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 23, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 22, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 21, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 20, 2021 $38.00 $38.00 $38.00 $38.00 0
Click to get the best stock tips daily for free!

About Five Prime Therapeutics

Five Prime Therapeutics Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; and is in Phase I/II... FPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT